UPDATE : Friday, October 19, 2018
상단여백
I-Mab to start trials for Genexine’s diabetes treatment by Lee Han-soo 2018-08-27 14:40
‘Xeomin’s side effect lowest among 5 botulinum toxins’ by Nam Doo-hyun 2018-08-27 14:39
Korean doctors favor original drugs after valsartan incident: survey by Lee Han-soo 2018-08-27 14:38
JW licenses out atopy treatment to Leo Pharma by Lee Han-soo 2018-08-24 16:08
DongA unveils new foot fungus treatment by Lee Han-soo 2018-08-24 14:34
라인
Gilead’s Genvoya comfortably tops HIV treatments by Nam Doo-hyun 2018-08-24 14:33
Roche Diagnostics donates ₩15 mil. to prevent child abuse by Marian Chu 2018-08-24 12:10
Hana Pharm performs P3 tests for new anesthetic agent by Marian Chu 2018-08-23 17:31
Boryung launches rapid influenza diagnostic kit by Marian Chu 2018-08-23 16:46
Ildong, Sandoz to ally in Asia-Pacific by Marian Chu 2018-08-23 15:11
라인
Myungmoon Pharm’s valsartan additionally suspended by Lee Hye-seon 2018-08-23 15:10
3 multinationals refuse to take pharma group’s anti-corruption system by Nam Doo-hyun 2018-08-23 12:01
Dong-A ST, Takara Bio signs licensing agreement for oncolytic virus therapy by Marian Chu 2018-08-23 11:49
Bridge Biotherapeutics presents preclinical trial results on ATX inhibitor by Marian Chu 2018-08-23 10:31
5 Korean biopharmaceuticals most active in P3 trials in 5 years by Marian Chu 2018-08-23 10:31
라인
Foreign CEOs to lead Korean units of Novartis, Galderma by Nam Doo-hyun 2018-08-22 13:56
Boehringer Ingelheim to present sub-analyses on Pradaxa at ESC Congress 2018 by Marian Chu 2018-08-22 12:31
Lixiana faces patent challenge in substance, composition by Lee Hye-seon 2018-08-22 11:16
Shire Korea gets approval for short bowel syndrome treatment by Marian Chu 2018-08-22 11:15
Pharma group will no longer provide souvenirs to medical workers by Lee Han-soo 2018-08-21 18:11
여백
여백
여백
Back to Top